{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T02:43:03Z","timestamp":1790908983465,"version":"4.1.0"},"reference-count":85,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,12]],"date-time":"2020-08-12T00:00:00Z","timestamp":1597190400000},"content-version":"vor","delay-in-days":11,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.heliyon.2020.e04716","type":"journal-article","created":{"date-parts":[[2020,8,24]],"date-time":"2020-08-24T16:00:24Z","timestamp":1598284824000},"page":"e04716","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Gene expression of serotonergic markers in peripheral blood mononuclear cells of patients with late-onset Alzheimer's disease"],"prefix":"10.1016","volume":"6","author":[{"given":"Masoud","family":"Neshan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arezoo","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Kazem","family":"Malakouti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahsa","family":"Zareii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4259-7672","authenticated-orcid":false,"given":"Ghasem","family":"Ahangari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2020.e04716_bib1","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/nrd3505","article-title":"The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics","volume":"10","author":"Karran","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.heliyon.2020.e04716_bib2","first-page":"e47","article-title":"2014 Alzheimer's disease facts and figures","volume":"10","author":"Fargo KaB","year":"2014","journal-title":"Alzheimer's Dementia"},{"key":"10.1016\/j.heliyon.2020.e04716_bib3","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nrneurol.2016.84","article-title":"Genetic variants in Alzheimer disease - molecular and brain network approaches","volume":"12","author":"Gaiteri","year":"2016","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.heliyon.2020.e04716_bib4","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.nrl.2015.03.012","article-title":"Una revisi\u00f3n de los avances en la terap\u00e9utica de la enfermedad de Alzheimer: estrategia frente a la prote\u00edna \u03b2-amiloide","volume":"33","author":"Folch","year":"2018","journal-title":"Neurologia"},{"key":"10.1016\/j.heliyon.2020.e04716_bib5","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.neuint.2017.04.008","article-title":"Effect of aging and Alzheimer's disease-like pathology on brain monoamines in mice","volume":"108","author":"Von Linstow","year":"2017","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.heliyon.2020.e04716_bib6","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3002369","article-title":"Alzheimer\u2019s disease: the challenge of the second century","volume":"3","author":"Holtzman","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.heliyon.2020.e04716_bib7","doi-asserted-by":"crossref","first-page":"180","DOI":"10.2741\/4480","article-title":"Molecular mechanisms of the genetic risk factors in pathogenesis of Alzheimer disease","volume":"22","author":"Kanatsu","year":"2017","journal-title":"Front Biosci. (Landmark Ed)"},{"key":"10.1016\/j.heliyon.2020.e04716_bib8","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1159\/000464422","article-title":"Molecular pathogenesis of Alzheimer's disease: an update","volume":"24","author":"Sanabria-Castro","year":"2017","journal-title":"Ann. Neurosci."},{"key":"10.1016\/j.heliyon.2020.e04716_bib9","doi-asserted-by":"crossref","first-page":"952","DOI":"10.2174\/1567205013666160314150501","article-title":"Molecular basis of familial and sporadic Alzheimer's disease","volume":"13","author":"Dorszewska","year":"2016","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.heliyon.2020.e04716_bib10","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s10522-012-9406-3","article-title":"Serotonin: from top to bottom","volume":"l4","author":"Fidalgo","year":"2013","journal-title":"Biogerontology"},{"key":"10.1016\/j.heliyon.2020.e04716_bib11","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/ajmg.b.30272","article-title":"Evaluating the comparability of gene expression in blood and brain","volume":"141","author":"Sullivan","year":"2006","journal-title":"Am. J. Med. Genet. Part B Neuropsychiatric Genet."},{"key":"10.1016\/j.heliyon.2020.e04716_bib12","doi-asserted-by":"crossref","first-page":"4821","DOI":"10.4049\/jimmunol.173.8.4821","article-title":"Th2 response of human peripheral monocytes involves isoform-specific induction of monoamine oxidase-A","volume":"173","author":"Chaitidis","year":"2004","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.heliyon.2020.e04716_bib13","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/sj.npp.1300330","article-title":"Differential involvement of 5-HT(1B\/1D) and 5-HT6 receptors in cognitive and non-cognitive symptoms in Alzheimer's disease","volume":"29","author":"Garcia-Alloza","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.heliyon.2020.e04716_bib14","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1749-6632.1991.tb00233.x","article-title":"Effect of citalopram, a selective 5-HT reuptake blocker, in emotionally disturbed patients with dementia","volume":"640","author":"Gottfries","year":"1991","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.heliyon.2020.e04716_bib15","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1021\/cn300095t","article-title":"5-HT4 receptors constitutively promote the non-amyloidogenic pathway of APP cleavage and interact with ADAM10","volume":"4","author":"Cochet","year":"2013","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.heliyon.2020.e04716_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0087014","article-title":"Regulation of amyloid precursor protein processing by serotonin signaling","volume":"9","author":"Pimenova","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.heliyon.2020.e04716_bib17","doi-asserted-by":"crossref","first-page":"5496","DOI":"10.1074\/jbc.M606215200","article-title":"The novel cellular mechanism of human 5-HT6 receptor through an interaction with Fyn","volume":"282","author":"Yun","year":"2007","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.heliyon.2020.e04716_bib18","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/j.1600-0447.1988.tb06412.x","article-title":"Platelet MAO-B activity and the psychopathology of Parkinson's disease, senile dementia and multi-infarct dementia","volume":"78","author":"Danielczyk","year":"1988","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.heliyon.2020.e04716_bib19","doi-asserted-by":"crossref","first-page":"5260","DOI":"10.1021\/jm020120c","article-title":"Novel dual inhibitors of AChE and MAO derived from hydroxy aminoindan and phenethylamine as potential treatment for Alzheimer's disease","volume":"45","author":"Sterling","year":"2002","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.heliyon.2020.e04716_bib20","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s00702-007-0674-z","article-title":"New insights into the structures and functions of human monoamine oxidases A and B","volume":"114","author":"Edmondson","year":"2007","journal-title":"J.\u00a0Neural. Transm."},{"key":"10.1016\/j.heliyon.2020.e04716_bib21","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s00702-014-1362-4","article-title":"Modulation of monoamine oxidase (MAO) expression in neuropsychiatric disorders: genetic and environmental factors involved in type A MAO expression","volume":"123","author":"Naoi","year":"2016","journal-title":"J.\u00a0Neural. Transm."},{"key":"10.1016\/j.heliyon.2020.e04716_bib22","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.pharmthera.2014.02.010","article-title":"Update on the pharmacology of selective inhibitors of MAO-A and MAO-B: focus on modulation of CNS monoamine neurotransmitter release","volume":"143","author":"Finberg","year":"2014","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.heliyon.2020.e04716_bib23","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1096\/fasebj.12.1.17","article-title":"Peripheral markers in testing pathophysiological hypotheses and diagnosing Alzheimer's disease","volume":"12","author":"Gasparini","year":"1998","journal-title":"FASEB J."},{"key":"10.1016\/j.heliyon.2020.e04716_bib24","first-page":"126","article-title":"The peripheral blood transcriptome dynamically reflects system wide biology: a potential diagnostic tool","volume":"147","author":"Liew","year":"2006","journal-title":"J.\u00a0Lab. Clin. Med."},{"key":"10.1016\/j.heliyon.2020.e04716_bib25","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1001\/jama.1993.03500180078038","article-title":"Population based norms for the minimental state examination by age and education level","volume":"269","author":"Grun","year":"1993","journal-title":"JAMA"},{"key":"10.1016\/j.heliyon.2020.e04716_bib26","first-page":"2018","article-title":"Standardized mini-mental state examination. Use and interpretation","volume":"47","author":"Vertesi","year":"2001","journal-title":"Can. Fam. Physician"},{"key":"10.1016\/j.heliyon.2020.e04716_bib27","first-page":"190","article-title":"Validation of a mini-mental state examination (MMSE) for the Persian population: a pilot study","volume":"17","author":"Ansari","year":"2010","journal-title":"Appl. Neuropsychol."},{"key":"10.1016\/j.heliyon.2020.e04716_bib28","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0091-3057(01)00746-8","article-title":"Molecular, pharmacological and functional diversity of 5-HT receptors","volume":"71","author":"Hoyer","year":"2002","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.heliyon.2020.e04716_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2007.01.028","article-title":"The neuronal 5-HT3 receptor network after 20 years of research\u2014evolving concepts in management of pain and inflammation","volume":"560","author":"Faerber","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.heliyon.2020.e04716_bib30","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/acps.12986","article-title":"Serotonin and aggressive behaviour in children and adolescents: a systematic review","volume":"139","author":"Runions","year":"2019","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.heliyon.2020.e04716_bib31","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0006-8993(03)02554-X","article-title":"Reduced serotonin 5-HT1A receptor binding in the temporal cortex correlates with aggressive behavior in Alzheimer disease","volume":"974","author":"Lai","year":"2003","journal-title":"Brain Res."},{"key":"10.1016\/j.heliyon.2020.e04716_bib32","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1515\/tnsci-2016-0007","article-title":"The serotonergic system and cognitive function","volume":"7","author":"\u0160trac","year":"2016","journal-title":"Transl. Neurosci."},{"key":"10.1016\/j.heliyon.2020.e04716_bib33","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/00002093-200210000-00001","article-title":"Relative frequencies of Alzheimer disease, Lewy body, vascular and frontotemporal dementia, and hippocampal sclerosis in the State of Florida Brain Bank","volume":"16","author":"Barker","year":"2002","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"10.1016\/j.heliyon.2020.e04716_bib34","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1159\/000116984","article-title":"Staging of Alzheimer-related cortical destruction","volume":"33","author":"Braak","year":"1993","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.heliyon.2020.e04716_bib35","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1037\/a0029857","article-title":"The natural history of cognitive decline in Alzheimer's disease","volume":"27","author":"Wilson","year":"2012","journal-title":"Psychol. Aging"},{"key":"10.1016\/j.heliyon.2020.e04716_bib36","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1001\/jama.287.18.2335","article-title":"Alzheimer disease","volume":"287","author":"Cummings","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.heliyon.2020.e04716_bib37","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1016\/j.bbadis.2011.08.012","article-title":"Brain aging, Alzheimer's disease, and mitochondria","volume":"1812","author":"Swerdlow","year":"2011","journal-title":"Biochimica et Biophysica Acta (BBA) Molecular Basis Dis"},{"key":"10.1016\/j.heliyon.2020.e04716_bib38","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jalz.2013.02.003","article-title":"Alzheimer\u2019s Association (2013) Alzheimer\u2019s disease facts and figures","volume":"9","author":"Thies","year":"2013","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.heliyon.2020.e04716_bib39","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1146\/annurev-pharmtox-011613-135932","article-title":"Emerging therapeutics for Alzheimer's disease","volume":"54","author":"Chiang","year":"2014","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.heliyon.2020.e04716_bib40","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.jagp.2017.01.001","article-title":"Molecular imaging of the nicotinic cholinergic receptor in alzheimer disease","volume":"25","author":"Smith","year":"2017","journal-title":"Am. J. Geriatr. Psychiatr."},{"key":"10.1016\/j.heliyon.2020.e04716_bib41","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1471-2202-7-36","article-title":"Serotonin 5-HT 2A and 5-HT 6 receptors in the prefrontal cortex of Alzheimer and normal aging patients","volume":"7","author":"Lorke","year":"2006","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.heliyon.2020.e04716_bib42","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.neurobiolaging.2010.03.023","article-title":"Loss of serotonin 2A receptors exceeds loss of serotonergic projections in early Alzheimer's disease: a combined [11C]DASB and [18F]altanserin-PET study","volume":"33","author":"Marner","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.heliyon.2020.e04716_bib43","doi-asserted-by":"crossref","first-page":"9504","DOI":"10.1073\/pnas.86.23.9504","article-title":"Circumscribed changes of the cerebral cortex in neuropsychiatric disorders of later life","volume":"86","author":"Bowen","year":"1989","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.heliyon.2020.e04716_bib44","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/0022-510X(91)90193-B","article-title":"Cortical serotonin-S2 receptor binding in Lewy body dementia, Alzheimer's and Parkinson's diseases","volume":"106","author":"Cheng","year":"1991","journal-title":"J.\u00a0Neurol. Sci."},{"key":"10.1016\/j.heliyon.2020.e04716_bib45","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s00213-004-2077-2","article-title":"Loss of serotonin 5-HT2A receptors in the postmortem temporal cortex correlates with rate of cognitive decline in Alzheimer's disease","volume":"179","author":"Lai","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.heliyon.2020.e04716_bib46","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s00213-004-2077-2","article-title":"Loss of serotonin 5-HT 2A receptors in the postmortem temporal cortex correlates with rate of cognitive decline in Alzheimer\u2019s disease","volume":"179","author":"Lai","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.heliyon.2020.e04716_bib47","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1016\/j.neurobiolaging.2007.04.011","article-title":"Reduced 5-HT2A receptor binding in patients with mild cognitive impairment","volume":"29","author":"Hasselbalch","year":"2008","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.heliyon.2020.e04716_bib48","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1741-7015-11-28","article-title":"Depression pathogenesis and treatment: what can we learn from blood mRNA expression?","volume":"11","author":"Hepgul","year":"2013","journal-title":"BMC Med."},{"key":"10.1016\/j.heliyon.2020.e04716_bib49","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0091-3057(92)90449-P","article-title":"Ondansetron and arecoline prevent scopolamine-induced cognitive deficits in the marmoset","volume":"42","author":"Carey","year":"1992","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.heliyon.2020.e04716_bib50","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0014-2999(96)00586-9","article-title":"Itasetron (DAU 6215) prevents age-related memory deficits in the rat in a multiple choice avoidance task","volume":"311","author":"Pitsikas","year":"1996","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.heliyon.2020.e04716_bib51","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1006\/nlme.1998.3886","article-title":"5HT antagonists attenuate MK801-impaired radial arm maze performance in rats","volume":"71","author":"Boast","year":"1999","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.heliyon.2020.e04716_bib52","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.pnpbp.2014.12.002","article-title":"Effect of the multimodal acting antidepressant vortioxetine on rat hippocampal plasticity and recognition memory","volume":"58","author":"B\u00e9try","year":"2015","journal-title":"Prog. Neuro Psychopharmacol. Biol. Psychiatr."},{"key":"10.1016\/j.heliyon.2020.e04716_bib53","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3389\/fcvm.2017.00048","article-title":"The effects of serotonin in immune cells","volume":"4","author":"Herr","year":"2017","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.heliyon.2020.e04716_bib54","first-page":"354957","article-title":"Immunomodulatory effects mediated by serotonin","volume":"2015","author":"Arreola","year":"2015","journal-title":"J.\u00a0Immunol. Res."},{"key":"10.1016\/j.heliyon.2020.e04716_bib55","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.bbadis.2014.04.012","article-title":"Is Alzheimer's disease a systemic disease?","volume":"1842","author":"Morris","year":"2014","journal-title":"Biochimica et Biophysica Acta (BBA) Mol. Basis Dis."},{"key":"10.1016\/j.heliyon.2020.e04716_bib56","doi-asserted-by":"crossref","first-page":"240","DOI":"10.2174\/1570163813666151126215210","article-title":"Alternative viewpoint Against breast cancer based on selective serotonin receptors 5HTR3A and 5HTR2A antagonists that can mediate apoptosis in MCF-7 cell line","volume":"12","author":"Hejazi","year":"2015","journal-title":"Curr. Drug Discov. Technol."},{"key":"10.1016\/j.heliyon.2020.e04716_bib57","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/intimm\/dxh242","article-title":"5-Hydroxytryptamine modulates cytokine and chemokine production in LPS-primed human monocytes via stimulation of different 5-HTR subtypes","volume":"17","author":"D\u00fcrk","year":"2005","journal-title":"Int. Immunol."},{"key":"10.1016\/j.heliyon.2020.e04716_bib58","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.tins.2006.07.006","article-title":"The brain as a target of inflammation: common pathways link inflammatory and neurodegenerative diseases","volume":"29","author":"Zipp","year":"2006","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.heliyon.2020.e04716_bib59","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.neuint.2006.04.011","article-title":"Peripheral inflammatory mechanisms modulate microglial activation in response to mild impairment of oxidative metabolism","volume":"49","author":"Ke","year":"2006","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.heliyon.2020.e04716_bib60","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2013.00081","article-title":"Neuroinflammation and brain functional disconnection in Alzheimer's disease","volume":"5","author":"Baglio","year":"2013","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.heliyon.2020.e04716_bib61","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","article-title":"Neuroinflammation in Alzheimer's disease","volume":"14","author":"Heneka","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.heliyon.2020.e04716_bib62","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jalz.2016.02.010","article-title":"Neuroinflammation in Alzheimer's disease: current evidence and future directions","volume":"12","author":"Calsolaro","year":"2016","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.heliyon.2020.e04716_bib63","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.bbi.2015.07.021","article-title":"Microglia in Alzheimer's disease: a multifaceted relationship","volume":"55","author":"Elali","year":"2015","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.heliyon.2020.e04716_bib64","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.pneurobio.2016.01.001","article-title":"Astrogliosis: an integral player in the pathogenesis of Alzheimer's disease","volume":"144","author":"Osborn","year":"2016","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.heliyon.2020.e04716_bib65","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.5213\/inj.1632604.302","article-title":"Pathophysiological role of neuroinflammation in neurodegenerative diseases and psychiatric disorders","volume":"20","author":"Hong","year":"2016","journal-title":"Int. Neurourol. J."},{"issue":"1","key":"10.1016\/j.heliyon.2020.e04716_bib66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-015-1449-5","article-title":"Analyzing dendritic spine pathology in Alzheimer\u2019s disease: problems and opportunities","volume":"130","author":"Dorostkar","year":"2015","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.heliyon.2020.e04716_bib67","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1038\/jcbfm.2013.135","article-title":"Blood\u2013brain barrier dysfunction as a cause and consequence of Alzheimer's disease","volume":"33","author":"Erickson","year":"2013","journal-title":"J.\u00a0Cerebr. Blood Flow Metabol."},{"key":"10.1016\/j.heliyon.2020.e04716_bib68","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1111\/acel.12370","article-title":"Enhanced microglial pro-inflammatory response to lipopolysaccharide correlates with brain infiltration and blood\u2013brain barrier dysregulation in a mouse model of telomere shortening","volume":"14","author":"Raj","year":"2015","journal-title":"Aging Cell"},{"key":"10.1016\/j.heliyon.2020.e04716_bib69","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.bbi.2009.01.017","article-title":"Lipopolysaccharide alters the blood\u2013brain barrier transport of amyloid \u03b2 protein: a mechanism for inflammation in the progression of Alzheimer\u2019s disease","volume":"23","author":"Jaeger","year":"2009","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.heliyon.2020.e04716_bib70","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1212\/WNL.0b013e3181b6bb95","article-title":"Systemic inflammation and disease progression in Alzheimer disease","volume":"73","author":"Holmes","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.heliyon.2020.e04716_bib71","doi-asserted-by":"crossref","first-page":"60","DOI":"10.2174\/1871528114666150803152433","article-title":"Investigation of 5-HT2A gene expression in PBMCs of patients with allergic asthma","volume":"14","author":"Ahangari","year":"2015","journal-title":"Inflamm. Allergy - Drug Targets"},{"key":"10.1016\/j.heliyon.2020.e04716_bib72","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1080\/08039488.2016.1276624","article-title":"Increased levels of 5HT2A receptor mRNA expression in peripheral blood mononuclear cells of patients with major depression: correlations with severity and duration of illness","volume":"71","author":"Amidfar","year":"2017","journal-title":"Nord. J. Psychiatr."},{"key":"10.1016\/j.heliyon.2020.e04716_bib73","first-page":"2376","article-title":"New discernment of pathophysiological aspects of multiple sclerosis based on mono amino oxidase (MAO) and ion channel receptor 5HT3RA as activator of T-cells","volume":"4","author":"Deylami","year":"2017","journal-title":"J.\u00a0Mult Scler. (Foster City)"},{"key":"10.1016\/j.heliyon.2020.e04716_bib74","first-page":"150","volume":"87","author":"Sheikhha","year":"2013"},{"key":"10.1016\/j.heliyon.2020.e04716_bib75","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1017\/S1041610200006645","article-title":"Serotonin 5-HT2A receptor binding in platelets from patients with Alzheimer's disease or vascular dementia","volume":"12","author":"Spigset","year":"2000","journal-title":"Int. Psychogeriatr."},{"key":"10.1016\/j.heliyon.2020.e04716_bib76","article-title":"The role of serotonin receptors in Alzheimer\u2019s disease","author":"Butzlaff EP","year":"2016","journal-title":"Opera Medica Physiol."},{"key":"10.1016\/j.heliyon.2020.e04716_bib77","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/sj.mp.4002088","article-title":"Meta-analyses of genetic studies on major depressive disorder","volume":"13","author":"Lopez-Leon","year":"2008","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.heliyon.2020.e04716_bib78","series-title":"Chemistry and Biochemistry of Flavoenzymes: Volume II","author":"Muller","year":"2018"},{"key":"10.1016\/j.heliyon.2020.e04716_bib79","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0006-8993(98)01211-6","article-title":"Accumulation of 3, 4-dihydroxyphenylglycolaldehyde, the neurotoxic monoamine oxidase A metabolite of norepinephrine, in locus ceruleus cell bodies in Alzheimer's disease: mechanism of neuron death","volume":"816","author":"Burke","year":"1999","journal-title":"Brain Res."},{"key":"10.1016\/j.heliyon.2020.e04716_bib80","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0304-3940(02)00307-5","article-title":"Increased monoamine oxidase messenger RNA expression levels in frontal cortex of Alzheimer's disease patients","volume":"326","author":"Emilsson","year":"2002","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.heliyon.2020.e04716_bib81","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1192\/bjp.135.3.216","article-title":"Changes in the brain catecholamines in patients with dementia of Alzheimer type","volume":"135","author":"Adolfsson","year":"1979","journal-title":"Br. J. Psychiatr."},{"key":"10.1016\/j.heliyon.2020.e04716_bib82","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1159\/000212870","article-title":"Brain neurotransmitters in aging and dementia: similar changes across diagnostic dementia groups","volume":"33","author":"Carlsson","year":"1987","journal-title":"Gerontology"},{"key":"10.1016\/j.heliyon.2020.e04716_bib83","first-page":"67","article-title":"The neurochemistry of Alzheimer's disease","volume":"97","author":"Engelborghs","year":"1997","journal-title":"Acta Neurol. Belg."},{"key":"10.1016\/j.heliyon.2020.e04716_bib84","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/BF01245229","article-title":"Monoamine neurons in aging and Alzheimer's disease","volume":"91","author":"Palmer","year":"1993","journal-title":"J.\u00a0Neural Transm. Gen. Section JNT"},{"key":"10.1016\/j.heliyon.2020.e04716_bib85","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1016\/j.neurobiolaging.2014.05.031","article-title":"Monoaminergic neurotransmitter alterations in postmortem brain regions of depressed and aggressive patients with Alzheimer's disease","volume":"35","author":"Vermeiren","year":"2014","journal-title":"Neurobiol. Aging"}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844020315590?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844020315590?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T21:07:48Z","timestamp":1754600868000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844020315590"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":85,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S2405844020315590"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2020.e04716","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gene expression of serotonergic markers in peripheral blood mononuclear cells of patients with late-onset Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2020.e04716","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e04716"}}